9-37707505-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014907.3(FRMPD1):āc.191C>Gā(p.Thr64Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000365 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014907.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMPD1 | NM_014907.3 | c.191C>G | p.Thr64Ser | missense_variant | 3/16 | ENST00000377765.8 | NP_055722.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMPD1 | ENST00000377765.8 | c.191C>G | p.Thr64Ser | missense_variant | 3/16 | 1 | NM_014907.3 | ENSP00000366995.3 | ||
FRMPD1 | ENST00000539465.5 | c.191C>G | p.Thr64Ser | missense_variant | 3/16 | 1 | ENSP00000444411.1 | |||
ENSG00000255872 | ENST00000540557.1 | n.*1012-14240G>C | intron_variant | 5 | ENSP00000457548.1 | |||||
FRMPD1 | ENST00000359927.3 | c.*3C>G | downstream_gene_variant | 3 | ENSP00000439868.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000187 AC: 47AN: 251390Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135844
GnomAD4 exome AF: 0.000382 AC: 559AN: 1461612Hom.: 0 Cov.: 31 AF XY: 0.000366 AC XY: 266AN XY: 727120
GnomAD4 genome AF: 0.000197 AC: 30AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.191C>G (p.T64S) alteration is located in exon 3 (coding exon 2) of the FRMPD1 gene. This alteration results from a C to G substitution at nucleotide position 191, causing the threonine (T) at amino acid position 64 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at